JP2005538117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538117A5 JP2005538117A5 JP2004525527A JP2004525527A JP2005538117A5 JP 2005538117 A5 JP2005538117 A5 JP 2005538117A5 JP 2004525527 A JP2004525527 A JP 2004525527A JP 2004525527 A JP2004525527 A JP 2004525527A JP 2005538117 A5 JP2005538117 A5 JP 2005538117A5
- Authority
- JP
- Japan
- Prior art keywords
- film
- formulation
- film coat
- active ingredient
- coating composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 16
- 239000007888 film coating Substances 0.000 claims description 7
- 238000009501 film coating Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000004815 dispersion polymer Substances 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 8
- 229940075507 glyceryl monostearate Drugs 0.000 claims 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims 6
- 239000002831 pharmacologic agent Substances 0.000 claims 6
- 239000000853 adhesive Substances 0.000 claims 4
- 230000000181 anti-adherent effect Effects 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 229920003163 Eudragit® NE 30 D Polymers 0.000 claims 3
- 239000011324 bead Substances 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 239000006185 dispersion Substances 0.000 claims 2
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical group COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical group OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- 239000000048 adrenergic agonist Substances 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229960002237 metoprolol Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0202353A SE0202353D0 (sv) | 2002-08-01 | 2002-08-01 | New film coating |
| PCT/GB2003/003195 WO2004012718A1 (en) | 2002-08-01 | 2003-07-28 | New film coating |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005538117A JP2005538117A (ja) | 2005-12-15 |
| JP2005538117A5 true JP2005538117A5 (enExample) | 2006-09-07 |
Family
ID=20288667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004525527A Pending JP2005538117A (ja) | 2002-08-01 | 2003-07-28 | 新規フィルム・コーティング |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050238719A1 (enExample) |
| EP (1) | EP1572165A1 (enExample) |
| JP (1) | JP2005538117A (enExample) |
| AU (1) | AU2003281837A1 (enExample) |
| SE (1) | SE0202353D0 (enExample) |
| WO (1) | WO2004012718A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| EP1355633B1 (en) * | 2001-12-19 | 2005-01-19 | AstraZeneca AB | NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| ES2377729T3 (es) * | 2002-02-21 | 2012-03-30 | Valeant International (Barbados) Srl | Formulaciones de liberación modificada de al menos una forma de tramadol |
| US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
| SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
| CA2760037A1 (en) | 2009-05-12 | 2010-11-18 | Bpsi Holdings, Llc | Film coatings containing fine particle size detackifiers and substrates coated therewith |
| MX2015010449A (es) | 2013-02-13 | 2015-10-30 | Evonik Roehm Gmbh | Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos. |
| US12472149B2 (en) | 2015-07-17 | 2025-11-18 | BE Pharbel Manufacturing | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
| MA45553A (fr) * | 2016-06-30 | 2019-05-08 | Beckman Coulter Inc | Substrats chimioluminescents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
| US5292522A (en) * | 1989-06-20 | 1994-03-08 | Rohm Gmbh | Aqueous film coating agent for solid medicaments |
| DE3920082A1 (de) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung |
| US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
| US5871776A (en) * | 1995-01-31 | 1999-02-16 | Mehta; Atul M. | Controlled-release nifedipine |
| PT1207866E (pt) * | 1999-08-31 | 2005-02-28 | Gruenenthal Gmbh | Forma de administracao retardada contendo sacarinato de tramadol |
| SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| EP1355633B1 (en) * | 2001-12-19 | 2005-01-19 | AstraZeneca AB | NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
-
2002
- 2002-08-01 SE SE0202353A patent/SE0202353D0/xx unknown
-
2003
- 2003-07-28 AU AU2003281837A patent/AU2003281837A1/en not_active Abandoned
- 2003-07-28 US US10/523,553 patent/US20050238719A1/en not_active Abandoned
- 2003-07-28 JP JP2004525527A patent/JP2005538117A/ja active Pending
- 2003-07-28 EP EP03740845A patent/EP1572165A1/en not_active Withdrawn
- 2003-07-28 WO PCT/GB2003/003195 patent/WO2004012718A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2540159C (en) | Extended release venlafaxine formulation | |
| JP3616011B2 (ja) | 新規制御放出ビーズ、その製造方法、およびそれを含む多重ユニット製剤 | |
| US8557282B2 (en) | Extended release compositions comprising as active compound venlafaxine hydrochloride | |
| JP5431214B2 (ja) | ミルナシプランの持続性放出を伴うガレヌス製剤形態 | |
| JP2005514386A5 (enExample) | ||
| JP2009530298A5 (enExample) | ||
| JP2004522741A5 (enExample) | ||
| JP5876896B2 (ja) | 持続放出性剤形 | |
| WO2015193788A1 (en) | Formulation for oral administration containing mesalazine | |
| CN1419446A (zh) | 缓释制剂及其制法 | |
| US12156941B2 (en) | Centanafadine pharmaceutical formulations, and methods of making and using same | |
| US8871275B2 (en) | Extended release compositions comprising tolterodine | |
| JP2005538117A5 (enExample) | ||
| US10258577B2 (en) | Multilayer solid pharmaceutical dosage forms | |
| EP3638211B1 (en) | Delayed sustained release pharmaceutical compositions | |
| JP2008542394A (ja) | 少なくとも１つの形態のベンラファキシンの調節放出性組成物 | |
| JP7787190B2 (ja) | センタナファジン製剤ならびにその製造および使用方法 | |
| CN102293737A (zh) | 一种文拉法辛的缓释制剂 | |
| JP2025183214A (ja) | センタナファジン製剤ならびにその製造および使用方法 | |
| US20100303920A1 (en) | Aqueous Film Coating Composition / 841 | |
| US20140112995A1 (en) | Multi-layered, multiple unit pharmaceutical compositions | |
| WO2005016317A1 (en) | Process for manufacture of extended release pellets containing diltiazem hci | |
| EP3474825A1 (en) | Sustained release formulation comprising tizanidine | |
| CA2874677A1 (en) | Multi-layered, multiple unit pharmaceutical compositions | |
| HK1096853A (en) | Multilayer dosage form comprising a matrix that influences release of a modulatory substance |